Hematological Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Blood Transfusions and Silent Stroke

Regular blood transfusion therapy could significantly reduce the incidence of the recurrent cerebral infarcts in children with sickle cell anemia.

Investigational Hem. A Therapy

Baxter announced positive results from its Phase 3 trial of BAX 855, an extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A.

Retreatment Indication for Velcade

The update now includes dosing guidelines as well as safety and efficacy results for the use of Velcade.

Tranexamic Acid Aids Surg. Outcomes

The clotting drug tranexamic acid is effective in reducing the need for blood transfusions during orthopedic surgery.

Pacritinib for Myelofibrosis

The FDA has granted Fast Track designation to pacritinib for the treatment of intermediate and high risk myelofibrosis.

Imbruvica: Expanded Use

The FDA has approved the expanded use of Imbruvica to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

Hematological Reference Values

Review this chart on 'Hematological Reference Values' for quick information when you need it.

New Drug Product: Alprolix

Prevention and control of bleeding in hemophilia B.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Transformative Changes in the Management of Multiple MyelomaExternal web site

This symposium will address practical applications of an individualized approach to management of patients with ...

CME 0.50 Credits

Sign Up for Free e-newsletters